Clinical Trial Update: Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma [Phase 2]

View source ↗

Summary

This Phase 2 study evaluated the safety and efficacy of eculizumab in patients with mild allergic asthma; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma

Drugs mentioned

• SOLIRIS (eculizumab)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Allergic Asthma | Phase 2 | Status: COMPLETED